These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1929304

  • 1. Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro.
    Baba M, Ito M, Shigeta S, Tanaka H, Miyasaka T, Ubasawa M, Umezu K, Walker RT, De Clercq E.
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1430-3. PubMed ID: 1929304
    [Abstract] [Full Text] [Related]

  • 2. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
    Yuasa S, Sadakata Y, Takashima H, Sekiya K, Inouye N, Ubasawa M, Baba M.
    Mol Pharmacol; 1993 Oct; 44(4):895-900. PubMed ID: 7694070
    [Abstract] [Full Text] [Related]

  • 3. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M, Tanaka H, De Clercq E, Pauwels R, Balzarini J, Schols D, Nakashima H, Perno CF, Walker RT, Miyasaka T.
    Biochem Biophys Res Commun; 1989 Dec 29; 165(3):1375-81. PubMed ID: 2575380
    [Abstract] [Full Text] [Related]

  • 4. Highly potent and selective inhibition of human immunodeficiency virus type 1 by a novel series of 6-substituted acyclouridine derivatives.
    Baba M, De Clercq E, Tanaka H, Ubasawa M, Takashima H, Sekiya K, Nitta I, Umezu K, Walker RT, Mori S.
    Mol Pharmacol; 1991 Jun 29; 39(6):805-10. PubMed ID: 1711148
    [Abstract] [Full Text] [Related]

  • 5. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro.
    Baba M, Shigeta S, Yuasa S, Takashima H, Sekiya K, Ubasawa M, Tanaka H, Miyasaka T, Walker RT, De Clercq E.
    Antimicrob Agents Chemother; 1994 Apr 29; 38(4):688-92. PubMed ID: 7518216
    [Abstract] [Full Text] [Related]

  • 6. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB, Zhu QY, Ruprecht RM, Watanabe KA, Zeidler JM, Gold JW, Polsky B, Armstrong D, Chou TC.
    Antimicrob Agents Chemother; 1991 Oct 29; 35(10):2003-11. PubMed ID: 1722077
    [Abstract] [Full Text] [Related]

  • 7. Resistance of human immunodeficiency virus type 1 to acyclic 6-phenylselenenyl- and 6-phenylthiopyrimidines.
    Nguyen MH, Schinazi RF, Shi C, Goudgaon NM, McKenna PM, Mellors JW.
    Antimicrob Agents Chemother; 1994 Oct 29; 38(10):2409-14. PubMed ID: 7840579
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds.
    Brennan TM, Taylor DL, Bridges CG, Leyda JP, Tyms AS.
    Antiviral Res; 1995 Mar 29; 26(2):173-87. PubMed ID: 7541619
    [Abstract] [Full Text] [Related]

  • 10. Antiviral activities of nucleotide heterodimers against human immunodeficiency virus type 1 in vitro.
    Ijichi K, Fujiwara M, Mori K, Morozumi M, Machida H, Shigeta S, Konno K, Yokota T, Baba M.
    Antiviral Res; 1996 Jun 29; 31(1-2):115-20. PubMed ID: 8793015
    [Abstract] [Full Text] [Related]

  • 11. Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine.
    Johnson VA, Barlow MA, Chou TC, Fisher RA, Walker BD, Hirsch MS, Schooley RT.
    J Infect Dis; 1989 May 29; 159(5):837-44. PubMed ID: 2785146
    [Abstract] [Full Text] [Related]

  • 12. Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro.
    Chong KT, Pagano PJ, Hinshaw RR.
    Antimicrob Agents Chemother; 1994 Feb 29; 38(2):288-93. PubMed ID: 7514857
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1.
    Smith MS, Kessler JA, Rankin CD, Pagano JS, Kurtzberg J, Carter SG.
    Antimicrob Agents Chemother; 1993 Jan 29; 37(1):144-7. PubMed ID: 8431013
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
    Rosowsky A, Saha J, Fazely F, Koch J, Ruprecht RM.
    Biochem Biophys Res Commun; 1990 Oct 15; 172(1):288-94. PubMed ID: 2222476
    [Abstract] [Full Text] [Related]

  • 15. In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine.
    Dianzani F, Antonelli G, Turriziani O, Dong G, Capobianchi MR, Riva E.
    Antiviral Res; 1992 May 15; 18(1):39-52. PubMed ID: 1384427
    [Abstract] [Full Text] [Related]

  • 16. Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine.
    Levere RD, Gong YF, Kappas A, Bucher DJ, Wormser GP, Abraham NG.
    Proc Natl Acad Sci U S A; 1991 Mar 01; 88(5):1756-9. PubMed ID: 2000384
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro.
    Eron JJ, Johnson VA, Merrill DP, Chou TC, Hirsch MS.
    Antimicrob Agents Chemother; 1992 Jul 01; 36(7):1559-62. PubMed ID: 1324648
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
    Debyser Z, Vandamme AM, Pauwels R, Baba M, Desmyter J, De Clercq E.
    J Biol Chem; 1992 Jun 15; 267(17):11769-76. PubMed ID: 1376311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.